Neurobiological correlates of auditory processing in health and disease: an RDoC study

健康和疾病中听觉处理的神经生物学相关性:一项 RDoC 研究

基本信息

项目摘要

 DESCRIPTION (provided by applicant): This proposal focuses on the role of auditory perception, a subconstruct within the cognitive systems domain of the Research Domain Criteria (RDoC), in the pathophysiology of auditory perceptual disturbances in health and across traditional (DSM-IV and DSM-V) disease categories. The overall aim is to characterize the neurobiological and neurocomputational basis of auditory sensory learning to identify pathophysiological mechanisms leading to auditory perceptual disturbances and, specifically, auditory verbal hallucinations (AVH). We aim to recruit the following groups: schizophrenia and schizoaffective disorder with low- and high-severity AVH (n=15 and n=15, respectively), delusional disorder (delusional psychosis without AVH; n=15), tinnitus (auditory perceptual disturbances without AVH; n=15), and matched healthy controls (varying degrees of subclinical perceptual disturbances; n=30). We will obtain extensive clinical, neurocognitive, and genetic characterization, and multimodal imaging in all subjects: (1) PET measures of D2/3 receptors and DA storage/release capacity within the thalamus, striatum, and the midbrain, using [11C]PHNO and the amphetamine paradigm; (2) Model-based fMRI measures of sensory prediction-error signals in auditory regions during a probabilistic, auditory discrimination task; 3) MR spectroscopy measures of glutamate concentration in the auditory cortex; (4) Task-based and resting- state fMRI connectivity measures in sensory thalamo-cortical projections; (5) Whole genome sequencing based on blood DNA samples. We will test in the overall sample across diagnostic groups if auditory PE deficits predict AVH (SA1) and correlate with altered DA in striatum and thalamus (SA2) and with increased glutamate in the auditory cortex (SA3). We will also explore the relationship within the same subjects between DA and glutamate (EA1) and the relationships of auditory PE to connectivity between auditory thalamus and auditory cortex (EA2) and identify a set of candidate genes associated with auditory PE deficits (EA3). This RDoC proposal will lead to further understanding of the mechanisms of sensory learning and their perturbations in conditions associated with auditory perceptual alterations.
 描述(由申请人提供):该提案侧重于听觉感知的作用,这是研究领域标准(RDoC)认知系统领域内的一个子结构,在健康和传统(DSM-IV和DSM-V)疾病类别中听觉感知障碍的病理生理学中。总体目标是表征听觉感知学习的神经生物学和神经计算基础,以确定导致听觉感知障碍的病理生理机制,特别是听觉言语幻觉(AVH)。我们的目标是招募以下人群:精神分裂症和情感性精神障碍伴轻度和重度AVH(分别为n=15和n=15)、妄想性精神障碍(不伴AVH的妄想性精神病; n=15)、耳鸣(不伴AVH的听觉感知障碍; n=15)和匹配的健康对照组(不同程度的亚临床感知障碍; n=30)。我们将获得广泛的临床,神经认知和遗传特征,以及所有受试者的多模态成像:(1)使用[11 C]PHNO和安非他明范式,在丘脑,纹状体和中脑内D2/3受体和DA储存/释放能力的PET测量;(2)在概率听觉辨别任务期间听觉区域感觉预测错误信号的基于模型的fMRI测量; 3)听觉皮层中谷氨酸浓度的MR波谱测量;(4)感觉丘脑-皮层投射中基于任务和静息状态的fMRI连接测量;(5)基于血液DNA样品的全基因组测序。我们将在诊断组的总体样本中测试听觉PE缺陷是否预测AVH(SA 1),并与纹状体和丘脑中的DA改变(SA 2)以及听觉皮层中的谷氨酸盐增加(SA 3)相关。我们还将探讨DA和谷氨酸(EA 1)之间的关系和听觉PE的听觉丘脑和听觉皮层(EA 2)之间的连接,并确定一组候选基因与听觉PE赤字(EA 3)在同一主题。 这RDoC建议将导致进一步理解的感觉学习的机制和他们的扰动条件与听觉感知改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Anissa Abi-Dargham其他文献

Anissa Abi-Dargham的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Anissa Abi-Dargham', 18)}}的其他基金

Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
  • 批准号:
    10710181
  • 财政年份:
    2022
  • 资助金额:
    $ 73.25万
  • 项目类别:
Deep rTMS modulating insula synaptic density and smoking behavior in schizophrenia
深度 rTMS 调节精神分裂症患者的岛叶突触密度和吸烟行为
  • 批准号:
    10494515
  • 财政年份:
    2022
  • 资助金额:
    $ 73.25万
  • 项目类别:
Preliminary imaging studies of the kappa opioid receptors in schizophrenia and their relationship to dopamine function
精神分裂症κ阿片受体及其与多巴胺功能关系的初步影像学研究
  • 批准号:
    10304170
  • 财政年份:
    2020
  • 资助金额:
    $ 73.25万
  • 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
  • 批准号:
    8712557
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
Probing dopamine D2 receptor trafficking in schizophrenia
探索精神分裂症中的多巴胺 D2 受体贩运
  • 批准号:
    8584066
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
RC2 Alcohol-induced human striatal dopamine release related to alcoholism vulnera
RC2 酒精诱导的人纹状体多巴胺释放与酒精中毒伤病相关
  • 批准号:
    8128248
  • 财政年份:
    2011
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8102708
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8448257
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    7940012
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Dopamine Dysfunction in Schizophrenia
精神分裂症的多巴胺功能障碍
  • 批准号:
    8249495
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:

相似海外基金

Relationship between neurotoxicity and the chemical structures of amphetamines
安非他明的神经毒性与化学结构的关系
  • 批准号:
    25860103
  • 财政年份:
    2013
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for protein expression in amphetamines treated mouse heart : Challenge to the diagnosis for the sudden death of amphetamines abusers
寻找安非他明治疗小鼠心脏中的蛋白质表达:对安非他明滥用者猝死诊断的挑战
  • 批准号:
    22659138
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8312648
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8531900
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8715749
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Novel Functionally-Selective Serotonin 5HT2 Drugs for Amphetamines Abuse/Disorder
用于治疗安非他明滥用/疾病的新型功能选择性血清素 5HT2 药物
  • 批准号:
    8144930
  • 财政年份:
    2010
  • 资助金额:
    $ 73.25万
  • 项目类别:
Translational Genetics and Dopamine Signaling in Sensitivity to Amphetamines
安非他明敏感性中的转化遗传学和多巴胺信号传导
  • 批准号:
    7675601
  • 财政年份:
    2009
  • 资助金额:
    $ 73.25万
  • 项目类别:
Simultaneous determination of ephedrines, amphetamines, cocaine, cocaine metabolites, and opiates and interaction in the rat
大鼠体内麻黄碱、安非他明、可卡因、可卡因代谢物和阿片类药物的同时测定及其相互作用
  • 批准号:
    17590585
  • 财政年份:
    2005
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study for practical use of two chiral analyses of amphetamines by gas chromatography-mass spectrometry
气相色谱-质谱法对苯丙胺两种手性分析的实用化研究
  • 批准号:
    17590588
  • 财政年份:
    2005
  • 资助金额:
    $ 73.25万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical Pharmacology of 3,4-Methylenedioxy Amphetamines
3,4-亚甲二氧基安非他明的临床药理学
  • 批准号:
    6870119
  • 财政年份:
    2004
  • 资助金额:
    $ 73.25万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了